1-(5-Trifluoromethyl-pyridin-2-yl)-ethanone, 95.0%, 5g

Cyclohexane, min 99.5%, for synthesis, 2.5L, glass packaging

4-Cyclopropyl-1,3-thiazole-5-carboxylic acid, 95%, 250mg

2,4-Difluoro-3-(trifluoromethyl)benzoic acid, 97%, 250mg

4-(p-Tolylthio)thieno[2,3-c]pyridine-2-carboxamide>95.0%(HPLC)100mg

5-nitro-1H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one, 95%, 250mg

2,2,2-Trifluoro-1-(2-nitrophenyl)ethanone, 95.0%, 2.5g

(2S,4S)-tert-butyl 4-(acetylthio)-2-((tert-butoxycarbonyl(sulfamoyl)amino)methyl)pyrrolidine-1-carboxylate, 96%, 250mg

5-BROMO-7-METHOXY-1H-INDOLE, 95.0%, 5g

2-(5-BROMOTHIOPHEN-2-YL)ACETIC ACID, 95.0%, 10g

3-(thiophen-2-yl)isoxazol-5-amine, 95.0%, 250mg

5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 100g

anti-1,2,2,3,4,4-Hexamethylphosphetane 1-Oxide>98.0%(GC)5g